Contemporary management of voice and swallowing disorders in patients with advanced lung cancer

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 23, Issue 3, 2015, Pages 191-196

  Brady, Grainne C ^a   Carding, Paul N ^b   Bhosle, Jaishree ^a   Roe, Justin W G ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

advanced lung cancer; dysphagia; dysphonia; palliative care; rehabilitation

Indexed keywords

AFATINIB; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; ERLOTINIB; GEFITINIB; LOCAL ANESTHETIC AGENT; NAVELBINE; PACLITAXEL; PROTEIN TYROSINE KINASE INHIBITOR;

ADVANCED CANCER; ADVANCED LUNG CANCER; COMMUNICATION DISORDER; COMORBIDITY; DYSPHAGIA; DYSPHONIA; HUMAN; LARYNGOPLASTY; LUNG CANCER; NERVE COMPRESSION; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SPEECH THERAPY; SURGICAL TECHNIQUE; SWALLOWING; THRUSH; TUMOR INVASION; VOCAL CORD PARALYSIS; VOICE; VOICE DISORDER; XEROSTOMIA; COMPLICATION; DEGLUTITION DISORDERS; DISEASE MANAGEMENT; LUNG NEOPLASMS; PROCEDURES; VOICE DISORDERS;

DEGLUTITION DISORDERS; DISEASE MANAGEMENT; HUMANS; LARYNGOPLASTY; LUNG NEOPLASMS; QUALITY OF LIFE; SPEECH THERAPY; VOICE DISORDERS;

EID: 84960117236     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0000000000000155     Document Type: Review

References (45)

1. Cancer Research UK. Cancer statistics key facts lung cancer. 2014. http://publications.cancerresearchuk.org/downloads/Product/CS-KF-LUNG.pdf. [Accessed 9 December 2014]
2. NICE. The diagnosis and treatment of lung cancer (update). 2011. http://www.nice.org.uk/guidance. [Accessed 30 November 2014]
3. National Cancer Institute. Small cell lung cancer treatment. 2014. http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/healthprofes-sional/page1#Section-25. [Accessed 3 December 2014]
4. NICE. 2004. http://www.nice.org.uk/guidance/csgsp/evidence/supportive-and-palliative-care-the-manual-2. [Accessed 2 November 2004]
5. Roe JW, Leslie P, Drinnan MJ. Oropharyngeal dysphagia: the experience of patients with nonhead and neck cancers receiving specialist palliative care. Palliat Med 2007; 10:567-574.
6. Raber-Durlacher J, Brennan M, Verdonck-de Leeuw I, et al. Swallowing dysfunction in cancer patients. Support Care Cancer 2012; 20:433-443.
7. Camidge DR. The causes of dysphagia in carcinoma of the lung. J R Soc Med 2001; 94:567-572.
8. Sasaki CT, Leder SB. Comments on selected recent dysphagia literature. Dysphagia 2003; 18:64-68.
9. Amin R. Dysphagia in lung cancer. J R Soc Med 2002; 95:55-56.
10. Lee CF, Carding PN, Fletcher M. The nature and severity of voice disorders in lung cancer patients. Logoped Phoniatr Vocol 2008; 33:93-103.
11. Loughran S, Alves C, MacGregor FB. Current aetiology of unilateral vocal fold paralysis in a teaching hospital in the West of Scotland. J Laryngol Otol 2002; 116:907-910.
12. Huins C, Lobeck E, Roe J. Unilateral vocal cord paralysis in patients with lung cancer. Eur J Palliat Care 2009; 16:214-217.
13. Bhattacharyya N, Kotz T, Shapiro J. Dysphagia and aspiration with unilateral vocal cord immobility: incidence, characterization, and response to surgical treatment. Ann Otol Rhinol Laryngol 2002; 111:672-679.
14. Alves CB, Loughran S, MacGregor FB, et al. Bioplastique medialization therapy improves the quality of life in terminally ill patients with vocal cord palsy. Clin Otolaryngol 2002; 27:387-391.
15. Powell J, Carding P, Birdi R, Wilson JA. Injection laryngoplasty in the out-patient clinic under local anaesthetic: a case series of sixty-eight patients. Clin Otolaryngol 2014; 39:224-227.
16. Spector BC, Netterville JL, Billante C, et al. Quality-of-life assessment in patients with unilateral vocal cord paralysis. Otolaryngol Head Neck Surg 2001; 125:176-182.
17. Hassan WA, Darwish K, Shalan IM, et al. Aetiologic mechanisms of dysphagia in lung cancer: a case series. Egypt J Chest Dis Tuber 2014; 63:435-442.
18. Ahmet Dobrucali EC. Palliation of malignant esophageal obstruction and fistulas with self expandable metallic stents. World J Gastroenterol 2010; 16:5739-5745.
19. Leslie P, Drinnan MJ, Ford GA, Wilson JA. Swallow respiratory patterns and aging: presbyphagia or dysphagia? J Gerontol A Biol Sci Med Sci 2005; 60:391-395.
20. Logemann J. Evaluation and treatment of swallowing disorders. 2nd ed. Texas: PRO-ED; 1998.
21. Cohen SM, Elackattu A, Noordzij JP, et al. Palliative treatment of dysphonia and dysarthria. Otolaryngol Clin North Am 2009; 42:107-121.
22. National Cancer Institute. Tobacco statistics snapshot. 2012. http://www.cancer.gov/cancertopics/tobacco/statisticssnapshot. [Accessed 10 December 2014]
23. Diez-Gross R, Atwood CWJ Jr, Charles W Jr, et al. The coordination of breathing and swallowing in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179:559-565.
24. Martin-Harris B. Optimal patterns of care in patients with chronic obstructive pulmonary disease. Semin Speech Lang 2000; 21:311-321.
25. Awan SN. The effect of smoking on the dysphonia severity index in females. Folia Phoniatr Logop 2011; 63:65-71.
26. Tammemagi CM, Neslund-dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003; 103:792-802.
27. London Cancer Alliance. LCA Lung Cancer Clinical Guidelines. 2013. http://www.londoncanceralliance.nhs.uk/media/62369/Lung%20Cancer%20Clini cal%20Guidelines%20041213%20FINAL%20REV.pdf. [Accessed 27 October 2013]
28. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: non-small cell lung cancer version 2. NCCN; 2014.
29. De-Ruysscher D, Meerbeeck J, Vandecasteele K, et al. Radiation-induced oesophagitisinlung cancer patients. Strahlenther Onkol 2012; 188:564-567.
30. Altemur Karamustafaoglu Y, Yoruk Y. Self-expandable esophageal stents placement for the palliation of dysphagia as a result of lung cancer. Dis Esophagus 2010; 23:561-564.
31. Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB. Chemotherapy-associated oral sequelae in patients with cancers outside the head and neck region. J Pain Symptom Manage 2014; 48:1060-1069.
32. Quinn B, Potting CMJ, Stone R, et al. Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer 2008; 44:61-72.
33. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury. Cancer 2004; 100:1995-2025.
34. Mok TS, Wu Y, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361:947-957.
35. Yang JC, Hirsh V, Schuler M, et al. Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations. J Clin Oncol 2013; 31:3342-3350.
36. Langmore SE, Grillone G, Elackattu A, Walsh M. Disorders of swallowing: palliative care. Otolaryngol Clin North Am 2009; 42:87-105.
37. Bülow M, Martin-Harris B. The therapeutic swallow study. In: Ekberg E, editor. Dysphagia: diagnosis and treatment. Berlin: Springer; 2012. pp. 411-424.
38. Karagama Y, Hurren A, Carding P, Lindsey L. Short-term voice quality results following percutaneous medialisation of the paralysed vocal cord under local anaesthesia using calcium hydroxyapatite gel: how we do it. Clin Otolaryngol 2008; 33:362-366.
39. Kupferman ME, Acevedo J, Hutcheson KA, Lewin JS. Addressing an unmet need in oncology patients: rehabilitation of upper aerodigestive tract function. Ann Oncol 2011; 22:2299-2303.
40. Heuer RJ, Thayer Sataloff R, Emerich K, et al. Unilateral recurrent laryngeal nerve paralysis: the importance of 'preoperative' voice therapy. J Voice 1997; 11:88-94.
41. Kraus DH, Ali MK, Ginsberg RJ, et al. Vocal cord medialization for unilateral paralysis associated with intrathoracic malignancies. J Thorac Cardiovasc Surg 1996; 111:334-339.
42. Nayak VK, Bhattacharyya N, Kotz T, Shapiro J. Patterns of swallowing failure following medialization in unilateral vocal fold immobility. Laryngoscope 2002; 112:1840-1844.
43. Hughes RGM, Morrison M. Vocal cord medialization by transcutaneous injection of calcium hydroxylapatite. J Voice 2005; 19:674-678.
44. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13:790-801.
45. America Lung Association. Key facts about tobacco use among children and teenagers. 2010. http://www.lung.org/stop-smoking/about-smoking/facts-figures/children-teens-and-tobacco.html. [Accessed 3 December 2014]